DESNZ logo

Dottikon ES Holding BATS-CHIXE:DESNZ Stock Report

Last Price

CHF 260.00

Market Cap

CHF 3.6b

7D

0.2%

1Y

21.8%

Updated

30 Sep, 2024

Data

Company Financials +

Dottikon ES Holding AG

BATS-CHIXE:DESNZ Stock Report

Market Cap: CHF 3.6b

DESNZ Stock Overview

Manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide.

DESNZ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Rewards

Risk Analysis

No risks detected for DESNZ from our risk checks.

Dottikon ES Holding AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Dottikon ES Holding
Historical stock prices
Current Share PriceCHF 260.00
52 Week HighCHF 270.00
52 Week LowCHF 190.40
Beta1.09
11 Month Change-0.29%
3 Month Change2.77%
1 Year Change21.78%
33 Year Change-13.91%
5 Year Changen/a
Change since IPO35.14%

Recent News & Updates

Recent updates

Shareholder Returns

DESNZGB PharmaceuticalsGB Market
7D0.2%-0.7%1.2%
1Y21.8%4.2%8.7%

Return vs Industry: DESNZ exceeded the UK Pharmaceuticals industry which returned 4.2% over the past year.

Return vs Market: DESNZ exceeded the UK Market which returned 8.7% over the past year.

Price Volatility

Is DESNZ's price volatile compared to industry and market?
DESNZ volatility
DESNZ Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement6.8%
Market Average Movement4.7%
10% most volatile stocks in GB Market9.5%
10% least volatile stocks in GB Market2.5%

Stable Share Price: DESNZ has not had significant price volatility in the past 3 months.

Volatility Over Time: DESNZ's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1913726Markus Blocherdottikon.com

Dottikon ES Holding AG manufactures and sells performance chemicals, intermediates, and active pharmaceutical ingredients for the chemical, biotech, and pharmaceutical industries worldwide. The company’s chemicals and intermediates include amines, anilines, azaindoles, benzimidazoles, benzoic acid derivatives, benzyl compounds, boron building blocks, chiral compounds, cyclohexane derivatives, cyclopropyl building blocks, indazoles, indoles, N-heterocycles, nitrate esters, nitroaromatic compounds, O-heterocycles, phenols and anisoles, and pyridine building blocks. It also offers Dottisol, an isosorbide dimethyl ether for application as a solubility enhancer in cosmetic, pharma, and agro products, as well as a performance additive in various industries.

Dottikon ES Holding AG Fundamentals Summary

How do Dottikon ES Holding's earnings and revenue compare to its market cap?
DESNZ fundamental statistics
Market capCHF 3.58b
Earnings (TTM)CHF 80.63m
Revenue (TTM)CHF 332.98m

44.4x

P/E Ratio

10.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DESNZ income statement (TTM)
RevenueCHF 332.98m
Cost of RevenueCHF 121.22m
Gross ProfitCHF 211.76m
Other ExpensesCHF 131.13m
EarningsCHF 80.63m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Nov 29, 2024

Earnings per share (EPS)5.84
Gross Margin63.59%
Net Profit Margin24.21%
Debt/Equity Ratio11.3%

How did DESNZ perform over the long term?

See historical performance and comparison